NL930107I2 - Verbeteringen van of betrekking hebbende op 2,4-digesubstitueerde thiazoolderivaten. - Google Patents

Verbeteringen van of betrekking hebbende op 2,4-digesubstitueerde thiazoolderivaten.

Info

Publication number
NL930107I2
NL930107I2 NL930107C NL930107C NL930107I2 NL 930107 I2 NL930107 I2 NL 930107I2 NL 930107 C NL930107 C NL 930107C NL 930107 C NL930107 C NL 930107C NL 930107 I2 NL930107 I2 NL 930107I2
Authority
NL
Netherlands
Prior art keywords
relating
thiazole derivatives
disubstituted thiazole
disubstituted
derivatives
Prior art date
Application number
NL930107C
Other languages
English (en)
Other versions
NL930107I1 (nl
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL930107(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NL930107I1 publication Critical patent/NL930107I1/nl
Publication of NL930107I2 publication Critical patent/NL930107I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL930107C 1980-10-02 1993-06-29 Verbeteringen van of betrekking hebbende op 2,4-digesubstitueerde thiazoolderivaten. NL930107I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (2)

Publication Number Publication Date
NL930107I1 NL930107I1 (nl) 1993-10-18
NL930107I2 true NL930107I2 (nl) 1997-02-03

Family

ID=22712591

Family Applications (1)

Application Number Title Priority Date Filing Date
NL930107C NL930107I2 (nl) 1980-10-02 1993-06-29 Verbeteringen van of betrekking hebbende op 2,4-digesubstitueerde thiazoolderivaten.

Country Status (36)

Country Link
US (1) US4375547A (nl)
EP (1) EP0049618B1 (nl)
JP (1) JPS5791980A (nl)
KR (1) KR850001795B1 (nl)
AR (1) AR241439A1 (nl)
AU (1) AU542553B2 (nl)
BG (1) BG60249B2 (nl)
CA (1) CA1166248A (nl)
CS (1) CS227015B2 (nl)
CY (1) CY1351A (nl)
DD (1) DD200371A5 (nl)
DE (1) DE3171819D1 (nl)
DK (2) DK164056C (nl)
EG (1) EG15678A (nl)
ES (2) ES8301950A1 (nl)
FI (2) FI813058L (nl)
GB (1) GB2084581B (nl)
GR (1) GR75023B (nl)
HK (1) HK15987A (nl)
HU (1) HU188697B (nl)
IE (1) IE51603B1 (nl)
IL (1) IL63980A (nl)
LU (1) LU88293I2 (nl)
MX (1) MX5723A (nl)
MY (1) MY8700247A (nl)
NL (1) NL930107I2 (nl)
NO (1) NO155885C (nl)
NZ (1) NZ198523A (nl)
PH (1) PH18135A (nl)
PL (2) PL130526B1 (nl)
PT (1) PT73757B (nl)
RO (2) RO82215A (nl)
SU (1) SU1184443A3 (nl)
UA (1) UA6081A1 (nl)
YU (1) YU42728B (nl)
ZA (1) ZA816817B (nl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
DK164501C (da) * 1983-02-07 1992-11-23 Lilly Co Eli Fremgangsmaade til fremstilling af nizatidin og mellemprodukt til brug ved fremgangsmaaden
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
EP0285681B1 (de) * 1987-04-06 1993-03-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von Nitroethenderivaten
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
IL101915A (en) * 1991-05-21 1996-12-05 Lilly Co Eli Process for the preparation of nizididine intermediates and related compounds
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
DE69307310D1 (de) * 1992-05-12 1997-02-20 Zeria Pharm Co Ltd Neue quaternäre ammoniumsalze und deren medizinische verwendung
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
US6069256A (en) * 1996-09-11 2000-05-30 Knoll Aktiengesellschaft Process for the preparation of nizatidine
IT1299198B1 (it) * 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
JP2002529503A (ja) 1998-11-17 2002-09-10 ニトロメッド，インク． ニトロソ化及びニトロシル化ｈ２リセプターアンタゴニスト化合物及び組成物並びにその利用方法
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
WO2005115341A2 (en) * 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery
US20080045575A1 (en) * 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
EP3865120A1 (en) 2013-07-19 2021-08-18 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
CN110721164B (zh) 2013-12-04 2024-09-17 勃林格殷格翰动物保健有限公司 匹莫苯的改善的药物组合物
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
CA1166248A (en) 1984-04-24
PL130526B1 (en) 1984-08-31
IL63980A (en) 1986-04-29
RO85815B (ro) 1984-11-30
HK15987A (en) 1987-02-27
MY8700247A (en) 1987-12-31
YU236481A (en) 1983-10-31
EG15678A (en) 1986-12-30
NO155885B (no) 1987-03-09
PL238035A1 (en) 1983-02-28
JPH021141B2 (nl) 1990-01-10
PH18135A (en) 1985-04-03
DK167759B1 (da) 1993-12-13
IE812285L (en) 1982-04-02
RO82215A (ro) 1983-07-07
ES505950A0 (es) 1983-01-01
PT73757A (en) 1981-11-01
KR830007602A (ko) 1983-11-04
ES8306135A1 (es) 1983-05-01
IL63980A0 (en) 1982-01-31
KR850001795B1 (ko) 1985-12-21
PT73757B (en) 1983-01-13
RO85815A (ro) 1984-11-25
BG60249B1 (bg) 1994-03-24
GB2084581B (en) 1985-02-27
GR75023B (nl) 1984-07-12
EP0049618A1 (en) 1982-04-14
DK435181A (da) 1982-05-12
AU542553B2 (en) 1985-02-28
ES8301950A1 (es) 1983-01-01
ES514868A0 (es) 1983-05-01
ZA816817B (en) 1983-05-25
NZ198523A (en) 1985-12-13
MX5723A (es) 1993-12-01
NL930107I1 (nl) 1993-10-18
IE51603B1 (en) 1987-01-21
BG60249B2 (en) 1994-03-24
AR241439A1 (es) 1992-07-31
DK12391A (da) 1991-01-24
NO155885C (no) 1987-06-17
PL130626B1 (en) 1984-08-31
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
HU188697B (en) 1986-05-28
SU1184443A3 (ru) 1985-10-07
DK164056C (da) 1992-09-28
JPS5791980A (en) 1982-06-08
RO82215B (ro) 1983-06-30
US4375547A (en) 1983-03-01
GB2084581A (en) 1982-04-15
DK164056B (da) 1992-05-04
DD200371A5 (de) 1983-04-20
PL233295A1 (nl) 1982-12-20
FI813058L (fi) 1982-04-03
DK12391D0 (da) 1991-01-24
DE3171819D1 (en) 1985-09-19
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
NO813334L (no) 1982-04-05
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
YU42728B (en) 1988-12-31
EP0049618B1 (en) 1985-08-14
AU7594581A (en) 1982-04-08

Similar Documents

Publication Publication Date Title
NL930107I2 (nl) Verbeteringen van of betrekking hebbende op 2,4-digesubstitueerde thiazoolderivaten.
DK164700C (da) 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider eller -1,1-dioxider
NL7904337A (nl) Aminothiazoolderivaten.
ATE24320T1 (de) Azabicyclo-alkyl-derivate.
IT1193190B (it) 2,3,4,5-tetraidro-1h-3-benzazepine mercapto-sostituito
IT7923695A0 (it) Derivati di fenilpiperazina.
NL7900028A (nl) Pyrrolidonderivaten.
SE7803411L (sv) 2,6-dialkoxibensamider
IT7925083A0 (it) Derivati di cloroambucile.
IT7829897A0 (it) Acidi 1,2-benzisossazolossiacetici e composti correlati ad essi.
IT7919536A0 (it) Coloranti eterociclici.
PT69352A (de) 1,1-diphenylathen-derivate als mikrobizide
IT7950202A0 (it) Derivati alfa-aril-alfa alfa-bisomega-ammino bisostituiti alchilacetammidici ditati di proprieta'farmacologiche antiaritmia
IT1096333B (it) 1,2,4-triazolidin-3-oni e-tioni
FI791103A (fi) Direkt uppvaermd katod foer elektronroer
FI790152A (fi) Hydraulisk komposition
IT7919012A0 (it) Derivati di 11-alcanoil-4"-deossi-4"-isonitriloleandomicina.
NL7900303A (nl) Fenylpyrroolderivaten.
SE7813350L (sv) Substituerade 1,4-cyklohexadienkarboxylsyraderivat
IT7924017A0 (it) Perfezionamenti al o relativi al controllo di registro.
SU556030A1 (ru) Инструмент дл вскрыти тары
KE3680A (en) Improvements in or relating to 2,4-disubstituted thiazole derivatives
FI791080A (fi) 4,6-dihalo-steroider
DK264082A (da) 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranon dibenzofuranolderivater
DK430479A (da) 2,6-dihalogenbensylestere